Бикалутамид Тева 150 мг

Ülke: İsrail

Dil: Rusça

Kaynak: Ministry of Health

Aktif bileşen:

BICALUTAMIDE 150 MG

Mevcut itibaren:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodu:

L02BB03

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapötik grubu:

BICALUTAMIDE

Terapötik endikasyonlar:

In patients with locally advanced prostate cancer (T3-T4 any N M0 T1-T2 N+ M0) Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Yetkilendirme tarihi:

2009-05-01